JP2003522175A5 - - Google Patents

Download PDF

Info

Publication number
JP2003522175A5
JP2003522175A5 JP2001557867A JP2001557867A JP2003522175A5 JP 2003522175 A5 JP2003522175 A5 JP 2003522175A5 JP 2001557867 A JP2001557867 A JP 2001557867A JP 2001557867 A JP2001557867 A JP 2001557867A JP 2003522175 A5 JP2003522175 A5 JP 2003522175A5
Authority
JP
Japan
Prior art keywords
oxazolidinyl
morpholinyl
acetamide
oxo
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001557867A
Other languages
English (en)
Japanese (ja)
Other versions
JP5235256B2 (ja
JP2003522175A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/000657 external-priority patent/WO2001057035A1/en
Publication of JP2003522175A publication Critical patent/JP2003522175A/ja
Publication of JP2003522175A5 publication Critical patent/JP2003522175A5/ja
Application granted granted Critical
Publication of JP5235256B2 publication Critical patent/JP5235256B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001557867A 2000-02-02 2001-01-29 リネゾリド結晶形態ii Expired - Lifetime JP5235256B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02
US60/179,837 2000-02-02
PCT/US2001/000657 WO2001057035A1 (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii

Publications (3)

Publication Number Publication Date
JP2003522175A JP2003522175A (ja) 2003-07-22
JP2003522175A5 true JP2003522175A5 (https=) 2008-10-16
JP5235256B2 JP5235256B2 (ja) 2013-07-10

Family

ID=22658183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001557867A Expired - Lifetime JP5235256B2 (ja) 2000-02-02 2001-01-29 リネゾリド結晶形態ii

Country Status (30)

Country Link
EP (1) EP1255754B1 (https=)
JP (1) JP5235256B2 (https=)
KR (3) KR100864745B1 (https=)
CN (1) CN1221547C (https=)
AR (1) AR027261A1 (https=)
AT (1) ATE297920T1 (https=)
AU (1) AU782138B2 (https=)
BR (1) BR0107667A (https=)
CA (1) CA2395603C (https=)
CO (1) CO5261555A1 (https=)
CZ (1) CZ302292B6 (https=)
DE (1) DE60111497T2 (https=)
DK (1) DK1255754T3 (https=)
EA (1) EA004434B1 (https=)
EE (1) EE05197B1 (https=)
ES (1) ES2242728T3 (https=)
HU (1) HUP0301076A3 (https=)
IL (1) IL151010A0 (https=)
MX (1) MXPA02007471A (https=)
MY (1) MY122829A (https=)
NO (2) NO323459B1 (https=)
NZ (1) NZ520541A (https=)
PE (1) PE20011086A1 (https=)
PL (1) PL356433A1 (https=)
PT (1) PT1255754E (https=)
SI (1) SI1255754T1 (https=)
SK (1) SK287025B6 (https=)
TW (1) TWI297687B (https=)
WO (1) WO2001057035A1 (https=)
ZA (1) ZA200205162B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
PT1673370E (pt) 2003-10-16 2009-11-05 Symed Labs Ltd Forma cristalina de linezolida
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
CA2572207A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd. Solid forms of linezolid and processes for preparation thereof
US20060142283A1 (en) * 2004-06-29 2006-06-29 Judith Aronhime Crystalline form IV of linezolid
WO2006091731A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
MX2007002113A (es) * 2005-06-22 2007-04-27 Teva Pharma Formas polimorfas de maleato de tegaserod.
AU2006277017A1 (en) * 2005-07-20 2007-02-15 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical composition comprising linezolid form IV
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
EP2099299A4 (en) * 2006-10-23 2011-11-30 Concert Pharmaceuticals Inc OXAZOLIDINONE DERIVATIVES AND METHOD FOR THEIR USE
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
MX2012012627A (es) 2010-04-30 2013-05-09 Univ Indiana Res & Tech Corp Proceso para preparar linezolid.
EP2603505A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
EP2603506A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
WO2012114354A1 (en) * 2011-02-24 2012-08-30 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
EP2683696A1 (en) 2011-03-09 2014-01-15 Synthon BV Process for making crystalline form a of linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
IN2014DN06213A (https=) 2012-01-24 2015-10-23 Jubilant Life Sciences Ltd
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
EP2917189B1 (en) 2012-11-09 2016-08-17 Synthon BV Process for making linezolid
DK3541442T3 (da) 2016-11-16 2022-03-14 Persica Pharmaceuticals Ltd Antibiotiske formuleringer mod lændesmerter
DK3709970T3 (da) * 2017-11-16 2025-07-07 Persica Pharmaceuticals Ltd Linezolidformuleringer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
DK1114819T3 (da) * 1996-04-11 2008-04-14 Pharmacia & Upjohn Co Llc Fremgangsmåde til fremstilling af oxazolidinoner
EP1772453A1 (en) * 1997-11-07 2007-04-11 Pharmacia & Upjohn Company LLC Process to produce Oxazolidinones

Similar Documents

Publication Publication Date Title
JP2003522175A5 (https=)
JP2004538039A5 (https=)
LTPA2013018I1 (lt) 4-oksochinolino junginiai ir jų, kaip živ inregrazės inhibitorių, panaudojimas
JP2005526058A5 (https=)
IL176283A0 (en) Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
MXPA03000042A (es) Composiciones para cuidado bucal que comprende clorito.
EP1427926A4 (en) ROTARY HEAT ENGINE
JP2005510235A5 (https=)
DE60100927D1 (de) Verbesserter Internet Protocolpaketrouter
DE60200427D1 (de) Vernetzbare Fluorelastomerzusammensetzungen, ihre Herstellung und Verwendung
JP2007500753A5 (https=)
JP2000028062A5 (https=)
JPH101422A5 (https=)
EE9700014A (et) Uus peroraalne ravimvorm, mis sisaldab omeprasooli magneesiumsoola
JP2005536339A5 (https=)
IS2473B (is) Samsetning sem inniheldur N-(3-metoxý-5-metýlpýrasín-2-ýl)-2-(4-(1,3,4-oxadíasól-2-ýl)fenýl)pýridín-3-súlfónamíð (ZD4054), eða lyfjafræðilega viðurkennt salt þess, og EGFR TKI, eða lyfjafræðilega viðurkennt salt þess
DE60307918D1 (de) Rotationsdämpfer
JP2002240244A5 (https=)
AU2001291714A1 (en) Flywheel comprising an oscillation damper that adapts to the rotational speed
JP2004517961A5 (https=)
JP2005536763A5 (https=)
JP2005005118A5 (https=)
JP2003504349A5 (https=)
DK1240163T3 (da) 3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler
JP2002277470A5 (https=)